FinancialsNon-life Insurance
  • Price (EUR)43.34
  • Today's Change-0.43 / -0.98%
  • Shares traded374.58k
  • 1 Year change+12.25%
  • Beta1.1305
Data delayed at least 15 minutes, as of Dec 02 2022 16:35 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • ASRNL:AEX price moved over +1.02% to 43.64
  • ASRNL:AEX price falls below 15-day moving average to 43.58 at 09:05 GMT
  • ASRNL:AEX price rises above 15-day moving average to 43.66 at 10:25 GMT

Key statistics

On Friday, ASR Nederland NV (ASRNL:AEX) closed at 43.34, -6.37% below its 52-week high of 46.29, set on Apr 21, 2022.
52-week range
32.88Mar 07 202246.29Apr 21 2022
Markit short selling activity
Previous close43.77
Average volume433.90k
Shares outstanding149.83m
Free float149.51m
P/E (TTM)7.59
Market cap6.49bn EUR
EPS (TTM)5.71
Annual div (ADY)2.58
Annual div yield (ADY)5.95%
Div ex-dateAug 31 2022
Div pay-dateSep 05 2022
Data delayed at least 15 minutes, as of Dec 02 2022 16:35 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.